what to eat after glp 1 injection on GLP-1 Medications for Long-Term Weight Loss GLP-1 is a hormone your

There are competing hypotheses to explain the GIP resistance

Patients who maintain high protein intake (1.2-1.6g per kg body weight daily) and prioritize whole foods over processed carbohydrates report better weight stability

Obesity Landscape - Final Thoughts Dosing The GLP-1 RA obesity market, driven by injectables, has seen historic levels of success, and near-term entrants are likely to provide more dosing options within the GLP-1 or GLP-1/GIP class Weight Loss Novel drugs in development are likely to be approved within the next 5 years, with improved weight loss efficacy compared to what Wegovy and Zepbound have demonstrated Body Comp The coming years will likely see increased data on muscle preservation and the quality of weight loss with novel MoAs, even if used in combination with GLP-1/incretin-targeting agents As the obesity market matures, how will patients think about the tradeoffs between efficacy, safety, and dosing/convenience with the availability of new drugs and more data

Pricing: Are costs predictable, with no hidden fees

Here is the evidence-based breakdown: 1